as on October 21, 2025 at 4:01 pm IST
Day's Low
Day's High
2.54%
Downside
0.07%
Upside
52 Week's Low
52 Week's High
5.85%
Downside
68.76%
Upside
as on October 21, 2025 at 4:01 pm IST
Market Cap
₹93.56 Cr
Return on Equity (ROE)
10.39
PE Ratio (TTM)
0Return on capital employed (ROCE)
13.6
Beta (LTM)
0.86
P/B Ratio
1.35
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-111.11
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Samrat Pharmachem Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 93.56 | 34.73% | 0.00 | 7 | 285 | |
NA | 177.68 | 6.15% | 0.00 | 24 | 115 | |
BUY | 7,470.60 | 2.23% | 0.72 | 3,597 | 4,565 | |
NA | 110.52 | 39.25% | 0.00 | 6 | 99 | |
NA | 504.01 | 19.28% | 0.00 | NA | NA |
Search interest for Samrat Pharmachem Ltd Stock has decreased by -6% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Samrat Pharmachem Ltd.
Samrat Pharmachem Ltd’s net profit fell -111.11% since last year same period to ₹0.23Cr in the Q1 2025-2026. On a quarterly growth basis, Samrat Pharmachem Ltd has generated 42.5% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Samrat Pharmachem Ltd has declared dividend of ₹1.00 per share on 30 May 2025 - translating a dividend yield of 0.67%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 129.1% return, outperforming this stock by 196.5%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 47.67% of holdings in Sep 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 13.2% return, outperforming this stock by 49.6%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 49.09% of holdings in Sep 2025 quarter
Price Dip
In the last 3 years, Samrat Pharma stock has moved down by -67.4%
Organisation | Samrat Pharmachem Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
CEO | Lalit Mehta |
E-voting on shares | Click here to vote |
Samrat Pharmachem Ltd share price today stands at ₹302.8 as on at the close of the market. Samrat Pharmachem Ltd share today touched a day high of ₹303 and a low of ₹295.1.
Samrat Pharmachem Ltd touched a 52 week high of ₹511 and a 52 week low of ₹285.1. Samrat Pharmachem Ltd share price today i.e. is closed at ₹302.8, which is -40.74% down from its 52 week high and 6.21% up from its 52 week low.
Samrat Pharmachem Ltd market capitalisation is ₹93.56 Cr as on .
To buy Samrat Pharmachem Ltd shares, you need to follow these steps:
Samrat Pharmachem Ltd trading volume is 231.00 as on . This means that 231.00 shares of Samrat Pharmachem Ltd were bought and sold on the stock market during today's trading session.